Bio / R&D
Alteogen Eyes KOSPI, Targets 60% Profit Margin
Alteogen Headquarters and Research Institute Alteogen announced on the 14th through a disclosure that it achieved consolidated sales of KRW 49 billion and an operating profit of KRW 26.7 billion in the third quarter of this year. Compared to last year, sales grew by 900%, and operating profit turned
2025.11.14